Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
Barclays Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...
BioPharma Dive4m
Drug compounders sue FDA over declaration ending Wegovy shortage
Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...
Lilly offers weight-loss drugs in vials at a discount to fight competition
Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an ...
Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...
United Therapeutics: A Unique Business With High Margins And Expansion Potential
United Therapeutics shows strong revenue growth, driven by Tyvaso, and maintains high margins and low debt burden. Read why I ...
The Motley Fool14h
Biggest Stock Losers Today
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our ...
IBEF16h
Indian E-commerce Industry Analysis
The Indian e-commerce industry is projected to reach US$ 325 billion by 2030 ... With over 821 million users, India was the second-largest internet market in the world with 117.6 billion UPI ...